Mylan wins lawsuit over insulin formulation patents
December 13, 2018 at 08:35 AM EST
U.S. Patent and Trademark Appeal Board rules that Mylan can continue making generic version of Sanofi's Lantus
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.